pCAGGS SARS-CoV-2 BA.2.75 Spike Citations (2)

Originally described in: Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine.
Tauzin A, Nicolas A, Ding S, Benlarbi M, Medjahed H, Chatterjee D, Dionne K, Gong SY, Gendron-Lepage G, Bo Y, Perreault J, Goyette G, Gokool L, Arlotto P, Morrisseau C, Tremblay C, Martel-Laferriere V, De Serres G, Levade I, Kaufmann DE, Cote M, Bazin R, Finzi A Cell Rep. 2023 Jan 31;42(1):111998. doi: 10.1016/j.celrep.2023.111998. Epub 2023 Jan 9. PubMed Journal

---

Articles Citing pCAGGS SARS-CoV-2 BA.2.75 Spike

Articles
Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants. Hwang J, Choi S, Kim BK, Son S, Yoon JH, Kim KW, Park W, Choo H, Kim S, Kim S, Yu S, Jung S, Jung ST, Song MS, Kim SJ, Kweon DH. J Nanobiotechnology. 2025 Jan 24;23(1):44. doi: 10.1186/s12951-025-03100-y. PubMed
Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation. Hwang J, Kim M, Jung Y, Kim S, Kim BK, Choi S, Park W, Oh H, Moon J, Yoon JH, Kim S, Kim H, Choo H, Park E, Kim MK, Moon S, Yu S, Jung S, Song MS, Chung WJ, Kweon DH. Biomacromolecules. 2025 Jul 14;26(7):4051-4068. doi: 10.1021/acs.biomac.5c00037. Epub 2025 Jun 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.